| Jan 30, 2026 |
Feb 3, 2026 |
MCGAULEY THOMAS
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2026 |
Jan 13, 2026 |
Davidson Michael H.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2026 |
Jan 13, 2026 |
Giordano Christopher Thomas
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2026 |
Jan 13, 2026 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2026 |
Jan 13, 2026 |
PROEHL GERALD T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2026 |
Jan 13, 2026 |
Almenoff June Sherie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2026 |
Jan 13, 2026 |
Doogan Declan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2026 |
Jan 13, 2026 |
Hunter Robyn
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 8, 2025 |
Dec 10, 2025 |
Rich Stuart
|
Chief Medical Officer |
Buy |
95.0
|
+5,000
|
65.33%
|
✗
|
$50.8K |
| Dec 2, 2025 |
Dec 5, 2025 |
Rich Stuart
|
Chief Medical Officer |
Buy |
91.3
|
+5,000
|
188.39%
|
✗
|
$45.6K |
| Nov 18, 2025 |
Nov 20, 2025 |
Giordano Christopher Thomas
|
CEO |
Buy |
91.3
|
+2,605
|
100.00%
|
✗
|
$20K |
| Nov 17, 2025 |
Nov 20, 2025 |
Almenoff June Sherie
|
Director |
Buy |
91.3
|
+1,993
|
100.00%
|
✗
|
$14.9K |
| Nov 17, 2025 |
Nov 19, 2025 |
MCGAULEY THOMAS
|
CFO |
Buy |
95.0
|
+8,000
|
100.00%
|
✗
|
$58.2K |
| Nov 17, 2025 |
Nov 19, 2025 |
Almenoff June Sherie
|
Director |
Buy |
91.3
|
+1,993
|
100.00%
|
✗
|
$14.9K |
| Jul 1, 2025 |
Jul 3, 2025 |
Almenoff June Sherie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2025 |
Jul 3, 2025 |
Davidson Michael H.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2025 |
Jul 3, 2025 |
Doogan Declan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2025 |
Jul 3, 2025 |
PROEHL GERALD T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2025 |
Jul 3, 2025 |
Hunter Robyn
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2025 |
May 20, 2025 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 16, 2025 |
May 20, 2025 |
Giordano Christopher Thomas
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 12, 2025 |
Dellora Investments LP
|
Other |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 10, 2025 |
Dellora Investments LP
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2024 |
Dec 12, 2024 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2024 |
Dec 12, 2024 |
PROEHL GERALD T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2024 |
Dec 12, 2024 |
Hunter Robyn
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2024 |
Dec 12, 2024 |
Giordano Christopher Thomas
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2024 |
Dec 12, 2024 |
Doogan Declan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2024 |
Dec 12, 2024 |
Davidson Michael H.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 10, 2024 |
Dec 12, 2024 |
Almenoff June Sherie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 6, 2024 |
MCGAULEY THOMAS
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 8, 2024 |
Aug 8, 2024 |
PROEHL GERALD T
|
Director |
Neutral |
90.0
|
+1,666
|
166600.00%
|
✗
|
- |
| Aug 8, 2024 |
Aug 8, 2024 |
Davidson Michael H.
|
Director |
Neutral |
90.0
|
+2,500
|
656.17%
|
✗
|
- |
| May 17, 2024 |
May 21, 2024 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2024 |
May 21, 2024 |
Giordano Christopher Thomas
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 12, 2024 |
HOFFMAN LAWRENCE R
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 21, 2022 |
Sep 23, 2022 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 11, 2022 |
Aug 12, 2022 |
Doogan Declan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 10, 2022 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 10, 2022 |
PROEHL GERALD T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 10, 2022 |
Hunter Robyn
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 10, 2022 |
Giordano Christopher Thomas
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 10, 2022 |
Doogan Declan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 10, 2022 |
Davidson Michael H.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 9, 2022 |
Jun 10, 2022 |
Almenoff June Sherie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 18, 2022 |
May 19, 2022 |
ARMISTICE CAPITAL, LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 12, 2022 |
Almenoff June Sherie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 31, 2022 |
Hunter Robyn
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 12, 2021 |
Dec 6, 2021 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 4, 2021 |
Lurier Eliot M
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 30, 2021 |
Aug 11, 2021 |
Doogan Declan
|
Director |
Neutral |
27.5
|
-567,871
|
-15.61%
|
✗
|
- |
|
Jul 15, 2021 |
Giordano Chrisopher Thomas
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 8, 2021 |
Jul 9, 2021 |
ARMISTICE CAPITAL, LLC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 6, 2021 |
Jul 8, 2021 |
DiTonno Anthony A
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2021 |
Jun 15, 2021 |
Mitchum James P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2021 |
Jun 15, 2021 |
PROEHL GERALD T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2021 |
Jun 15, 2021 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 10, 2021 |
Jun 15, 2021 |
Almenoff June Sherie
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2021 |
Jun 15, 2021 |
Doogan Declan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2021 |
Jun 15, 2021 |
Davidson Michael H.
|
Director |
Neutral |
90.0
|
+512,000
|
540.97%
|
✗
|
- |
|
Jun 15, 2021 |
Doogan Declan
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 15, 2021 |
Davidson Michael H.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 15, 2021 |
Jan 27, 2021 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
90.0
|
+666,098
|
100.00%
|
✗
|
- |
|
Jan 27, 2021 |
Rich Stuart
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2021 |
Jan 12, 2021 |
Jebsen Michael B
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2021 |
Jan 12, 2021 |
DiTonno Anthony A
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 4, 2020 |
Sep 9, 2020 |
ARMISTICE CAPITAL, LLC
|
Director |
Buy |
68.8
|
+32,000
|
0.53%
|
✗
|
$45.5K |
| Sep 1, 2020 |
Sep 3, 2020 |
ARMISTICE CAPITAL, LLC
|
Director |
Buy |
82.5
|
+86,000
|
1.11%
|
✗
|
$123.2K |
| Aug 27, 2020 |
Aug 31, 2020 |
ARMISTICE CAPITAL, LLC
|
Director |
Buy |
68.8
|
+32,000
|
0.57%
|
✗
|
$47K |
| Aug 24, 2020 |
Aug 26, 2020 |
ARMISTICE CAPITAL, LLC
|
10% Owner |
Buy |
65.0
|
+34,903
|
0.47%
|
✗
|
$52.7K |
| Aug 19, 2020 |
Aug 21, 2020 |
ARMISTICE CAPITAL, LLC
|
Director |
Buy |
90.0
|
+311,481
|
4.67%
|
✗
|
$460.4K |
|
Jul 21, 2020 |
Maher Illya Keith
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 16, 2020 |
ARMISTICE CAPITAL, LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2020 |
Jun 15, 2020 |
RALLIS CHRIS A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 18, 2020 |
May 19, 2020 |
BLANCK RONALD R
|
Director |
Buy |
90.0
|
+5,000
|
470.81%
|
✗
|
$4.8K |
| Mar 1, 2020 |
May 15, 2020 |
Jebsen Michael B
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2020 |
May 15, 2020 |
PROEHL GERALD T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2020 |
May 15, 2020 |
Mitchum James P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2020 |
May 15, 2020 |
BLANCK RONALD R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2020 |
May 15, 2020 |
DiTonno Anthony A
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 1, 2018 |
Apr 22, 2019 |
DiTonno Anthony A
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2018 |
Apr 18, 2019 |
Mitchum James P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2018 |
Apr 18, 2019 |
DiTonno Anthony A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2018 |
Apr 18, 2019 |
BLANCK RONALD R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2018 |
Apr 18, 2019 |
PROEHL GERALD T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 31, 2018 |
Aug 7, 2018 |
Jebsen Michael B
|
CFO |
Buy |
91.3
|
+5,720
|
19.75%
|
✗
|
$35.8K |
| Mar 30, 2018 |
Apr 5, 2018 |
Jebsen Michael B
|
CFO |
Buy |
91.3
|
+6,425
|
109.18%
|
✗
|
$34.8K |
| Dec 29, 2017 |
Jan 2, 2018 |
Jebsen Michael B
|
CFO |
Buy |
55.0
|
+98
|
0.14%
|
✗
|
$42.1 |
| Dec 18, 2017 |
Dec 20, 2017 |
BLANCK RONALD R
|
Director |
Buy |
90.0
|
+12,950
|
181.14%
|
✗
|
$5.9K |
| Nov 14, 2017 |
Nov 20, 2017 |
BLANCK RONALD R
|
Director |
Sell |
27.5
|
-12,950
|
-64.43%
|
✗
|
$5.1K |
| Jul 31, 2017 |
Jul 31, 2017 |
Jebsen Michael B
|
CFO |
Buy |
55.0
|
+54
|
0.08%
|
✗
|
$35.1 |
| Apr 15, 2017 |
Apr 18, 2017 |
Jebsen Michael B
|
CFO |
Buy |
55.0
|
+56
|
0.08%
|
✗
|
$30.2 |
| Apr 3, 2017 |
Apr 5, 2017 |
Jebsen Michael B
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 15, 2017 |
Mar 20, 2017 |
Kelley John P
|
CEO |
Sell |
90.0
|
+116,421
|
9.98%
|
✗
|
$66K |
| Dec 15, 2016 |
Dec 20, 2016 |
Jebsen Michael B
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 15, 2016 |
Dec 20, 2016 |
Kelley John P
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 19, 2016 |
Dec 20, 2016 |
Jebsen Michael B
|
CFO |
Buy |
55.0
|
+49
|
0.07%
|
✗
|
$101.4 |
| Nov 22, 2016 |
Nov 29, 2016 |
PROEHL GERALD T
|
Director |
Buy |
91.3
|
+29,882
|
100.00%
|
✗
|
$50K |
|
Nov 29, 2016 |
PROEHL GERALD T
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 21, 2016 |
Nov 22, 2016 |
Mitchum James P.
|
Director |
Buy |
91.3
|
+7,000
|
36.84%
|
✗
|
$10.6K |